Dudum Andrew's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Apr 8, 2024
- Accession no.
- 0001773751-24-000098
- Filed
- Apr 8, 2024
- Trade date
- Apr 4, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.96M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dudum AndrewCIK 0001837796 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2024 | Class A Common Stock | MOption exerciseAcquired | +188,888 | $2.43 | +$458,997.84 | 188,888 | Direct | |
| Apr 4, 2024 | Class A Common Stock | SSaleDisposed | −93,521 | $14.96F2 | −$1,399,074.16 | 95,367 | Direct | |
| Apr 4, 2024 | Class A Common Stock | SSaleDisposed | −923 | $15.63F3 | −$14,426.49 | 94,444 | Direct | |
| Apr 4, 2024 | Class A Common Stock | SSaleDisposed | −93,434 | $14.97F4 | −$1,398,706.98 | 1,010 | Direct | |
| Apr 4, 2024 | Class A Common Stock | SSaleDisposed | −1,010 | $15.63F5 | −$15,786.3 | 0 | Direct | |
| Apr 4, 2024 | Class A Common Stock | SSaleDisposed | −128,546 | $14.70F6 | −$1,889,626.2 | 1,470,764 | Indirect | |
| Apr 4, 2024 | Class A Common Stock | SSaleDisposed | −15,898 | $15.39F7 | −$244,670.22 | 1,454,866 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2024 | Class A Common Stock | MOption exerciseDisposed | −188,888 | $0.00 | $0 | 1,526,232 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.44 - 15.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.47 - 15.66. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.45 - 15.43. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.47 - 15.685. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.20 - 15.17. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.28 - 15.71. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.